HCP Live

Articles by HCP Live

Case 2: Relationship Between LDL and Major Adverse CV Events

ByHCP Live

February 9th 2021

Case 2: Combination of Device and Drug for Patients With Stents

ByHCP Live

February 9th 2021

The Role of L-Glutamine in Treating SCD

ByHCP Live

February 5th 2021

Mechanism of Action of Hydroxyurea

ByHCP Live

February 5th 2021

Managing AD and Treatment Adherence in Patients of Color

ByHCP Live

February 5th 2021

Burdens of Atopic Dermatitis in Patients With Skin of Color

ByHCP Live

February 5th 2021

Roles and Communication in Treatment in DTC

ByHCP Live

February 4th 2021

Management of DTC in Clinical Practice

ByHCP Live

February 4th 2021

Selecting Therapy to Treat C. Difficile.

ByHCP Live

February 1st 2021

C. Difficile: Updates to Clinical Practice Guidelines

ByHCP Live

February 1st 2021

C. Difficile Risk Factors and Manifestation

ByHCP Live

February 1st 2021

C. Difficile: Clinical Practice Guidelines and Treatment Options

ByHCP Live

February 1st 2021

Screening for C. Difficile

ByHCP Live

February 1st 2021

Testing for C. Difficile Infections

ByHCP Live

February 1st 2021

C. Difficile: A Differential Diagnosis

ByHCP Live

February 1st 2021

Recurrent C. Difficile

ByHCP Live

February 1st 2021

Case 2: Triple Antiplatelet Therapy in Patients With Stents

ByHCP Live

February 1st 2021

Case 1: THEMIS Trial and Subgroup Analysis With Revascularization

ByHCP Live

February 1st 2021

Case 1: Choice of Therapy for Peripheral Artery Disease

ByHCP Live

February 1st 2021

Case 1: Antithrombotic Regimen in High-Risk Patient

ByHCP Live

February 1st 2021

Rationale and Study Design of the VOYAGER PAD Trial

ByHCP Live

February 1st 2021

COMPASS Trial: Subgroup Analysis and Implications

ByHCP Live

February 1st 2021

Role of NOACs in Venous Thromboembolism and COMPASS Trial

ByHCP Live

February 1st 2021

How COVID-19 Has Impacted Patients With SCD

ByHCP Live

January 29th 2021

Complications of Sickle Cell Disease

ByHCP Live

January 29th 2021

Sickle Cell Disease Prevalence and Pathophysiology

ByHCP Live

January 29th 2021

Sickle Cell Disease QoL and Life Expectancy

ByHCP Live

January 29th 2021

Diagnosing and Assessing AD in Patients With Skin of Color

ByHCP Live

January 29th 2021

Clinical Presentation of AD in Skin of Color

ByHCP Live

January 29th 2021

Atopic Dermatitis in Diverse Racial and Ethnic Groups

ByHCP Live

January 29th 2021

HCP Live

Articles by HCP Live

Case 2: Relationship Between LDL and Major Adverse CV Events

Case 2: Combination of Device and Drug for Patients With Stents

The Role of L-Glutamine in Treating SCD

Mechanism of Action of Hydroxyurea

Managing AD and Treatment Adherence in Patients of Color

Burdens of Atopic Dermatitis in Patients With Skin of Color

Roles and Communication in Treatment in DTC

Management of DTC in Clinical Practice

Selecting Therapy to Treat C. Difficile.

C. Difficile: Updates to Clinical Practice Guidelines

C. Difficile Risk Factors and Manifestation

C. Difficile: Clinical Practice Guidelines and Treatment Options

Screening for C. Difficile

Testing for C. Difficile Infections

C. Difficile: A Differential Diagnosis

Recurrent C. Difficile

Case 2: Triple Antiplatelet Therapy in Patients With Stents

Case 1: THEMIS Trial and Subgroup Analysis With Revascularization

Case 1: Choice of Therapy for Peripheral Artery Disease

Case 1: Antithrombotic Regimen in High-Risk Patient

Rationale and Study Design of the VOYAGER PAD Trial

COMPASS Trial: Subgroup Analysis and Implications

Role of NOACs in Venous Thromboembolism and COMPASS Trial

How COVID-19 Has Impacted Patients With SCD

Complications of Sickle Cell Disease

Sickle Cell Disease Prevalence and Pathophysiology

Sickle Cell Disease QoL and Life Expectancy

Diagnosing and Assessing AD in Patients With Skin of Color

Clinical Presentation of AD in Skin of Color

Atopic Dermatitis in Diverse Racial and Ethnic Groups

Trending on HCPLive

Bringing Bronchiectasis Guidelines Into Everyday Practice

The Future of Bronchiectasis Care: Precision Medicine Ahead

Does Artificial Intelligence Worsen Health Care Disparities?

Sequencing Therapies for Bronchiectasis: A Practical Approach

Inhaled Antibiotics for Pseudomonas in Bronchiectasis